Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Knox (1960)
A New Penicillin (BRL 1241) Active Against Penicillin-resistant StaphylococciBritish Medical Journal, 2
W. Hewitt, S. Finegold, O. Monzon (1962)
Clinical experience with dimethoxyphenyl penicillin.Chemotherapia, 5
R. Fairbrother, G. Taylor (1961)
Sodium methicillin in routine therpay.Lancet, 1 7175
M. Barber, P. Waterworth (1962)
Antibacterial Activity of the PenicillinsBritish Medical Journal, 1
G. Stewart, H. Nixon, H. Coles, C. Kesson, D. Lawson, R. Thomas, J. Mishra, M. Mitchell, J. Semmens, T. Wade (1960)
Report on Clinical Use of BRL 1241 in Children with Staphylococcal and Streptococcal InfectionsBritish Medical Journal, 2
J. Geraci, R. Hoffmeister, D. Nichols, G. Needham (1962)
Preliminary clinical and laboratory experiences with a new oral penicillin: 5-methyl-3-phenyl-4-isoxazolyl penicillin.Proceedings of the staff meetings. Mayo Clinic, 37
A. Branch, K. Rodger, H. Tonning, R. Lee, E. Power (1962)
Laboratory and clinical experiences with a new oral synthetic penicillin, 5-methyl-3-phenyl-4-isoxazolyl penicillin.Canadian Medical Association journal, 86
L. P. Garrod (1960)
The Relative Antibacterial Activity of 4 PenicillinsBrit. Med. J., 2
J. Geraci, D. Nichols, W. Wellman (1962)
Vancomycin in serious staphylococcal infections.Archives of internal medicine, 109
S. M. Feingold , O. T. Monzon, E. E. Sweeney, H. G. Dangerfield, B. T. Blackman (1960)
Symposium on the New Dimethoxyphenylpenicillin
Abstract The new penicillinase-resistant semisynthetic penicillins methicillin and oxacillin have proved effective against staphylococci in vitro and in vivo. They are considered the answer to the staphylococcal problem. It has been observed that the antibacterial activity of the new penicillins is much inferior to that of benzylpenicillin since a large number of bacteria survived despite their action.1-3,7 In using methicillin at first and oxacillin lately we have been struck by the slowness of response, especially of the septicemia and endocarditis patients. In the 2 representative cases that we describe here, Staphylococcus was isolated from the blood stream while the patients were under treatment with methicillin or oxacillin. A large number of survivors have been observed in in vitro experiments in high concentrations of the antibiotics. Report of Cases Case 1.— This patient was a 19-year-old male with a congenital aortic stenosis. Staphylococcal endocarditis was diagnosed in January, 1961. The fever References 1. Cillocycline was known before as penimpcycline. 2. Knox, R.: A New Penicillin (BRL 1241) Active Against Penicillin-Resistant Staphylococci , Brit. Med. J. 2:690-693, 1960.Crossref 3. Garrod, L. P.: The Relative Antibacterial Activity of 4 Penicillins , Brit. Med. J. 2:1695-1696, 1960.Crossref 4. Barber, M., and Waterworth, P. M.: Antibacterial Activity of the Penicillins , Brit. Med. J. 1:1159-1164, 1962.Crossref 5. Geraci, J. E.; Nichols, D. R., and Wellman, W. E.: Vancomycin in Serious Staphylococcal Infections , Arch. Intern. Med. 109:507-515, 1962.Crossref 6. Stewart, G. T.; Nixon, H. H.; Coles, H. M. T.; Kesson, C. W.; Lawson, D.; Thomas, R. G.; Mishra, J. N.; Mitchell, M. E.; Semmens, J. M., and Wade, T. H. H.: Report on Clinical Use of BRL 1241 in Children with Staphylococcal and Streptococcal Infections , Brit. Med. J. 2:703-706, 1960.Crossref 7. Fairbrother, R. W., and Taylor, G.: Sodium Methicillin in Routine Therapy , Lancet 1:473-476, 1961.Crossref 8. Feingold, S. M.; Monzon, O. T.; Sweeney, E. E.; Dangerfield, H. G.; Blackman, B. T., and Hewitt, W. L.: Laboratory Experiences with Dimethoxyphenyl Penicillin , in Symposium on the New Dimethoxyphenylpenicillin , State University of New York, Syracuse, N.Y., 1960, pp. 26-36. 9. Smith, J. M., and Counts, G. W.: Laboratory and Clinical Studies of Dimethoxyphenyl Penicillin, in Symposium,7 pp. 83-92. 10. Branch, A.; Rodger, K. C., and Power, E. E.: Clinical and Laboratory Experiences with Dimethoxyphenyl Penicillin, in Symposium,7 pp. 93-100. 11. Yow, E. M., and Nassar, H. A.: Report on the Laboratory and Clinical Evaluation of Dimethoxyphenyl Penicillin, in Symposium,7 pp. 183-193. 12. Hewitt, W. L.; Monzon, O.; Dangerfield, H. G.; Blackman, B.; Kudinoff, Z., and Finegold, S. M.: Clinical Experience with Dimethoxyphenyl Penicillin, in Symposium,7 pp. 127-145. 13. Bunn, P.; Knight, R., and Amberg, J.: Some Notes About Dimethoxyphenyl Penicillin, in Symposium,7 pp. 172-182. 14. Branch, A.; Rodger, K. C.; Tonning, H. O.; Lee, R. W., and Power, E. E.: Laboratory and Clinical Experiences with a New Oral Synthetic Penicillin, 5-Methyl-3-Phenyl-4-Isoxazolyl Penicillin , Canad. Med. Ass. J. 86:97-101, 1962. 15. Geraci, J. E.; Hoffmeister, R. T.; Nichols, D. R., and Needham, G. M.: Preliminary Clinical and Laboratory Experiences with a New Oral Penicillin: 5-Methyl-3-Phenyl-4-Isoxazolyl Penicillin , Proc. Mayo Clin. 37:137-149, 1962.
Archives of Internal Medicine – American Medical Association
Published: Jun 1, 1963
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.